MyMD Pharmaceuticals News

MYMDDelisted Stock  USD 1.82  0.02  1.09%   
About 61% of MyMD Pharmaceuticals' investor base is looking to short. The analysis of current outlook of investing in MyMD Pharmaceuticals suggests that many traders are alarmed regarding MyMD Pharmaceuticals' prospects. The current market sentiment, together with MyMD Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use MyMD Pharmaceuticals stock news signals to limit their universe of possible portfolio assets.
  
over a year ago at finance.yahoo.com         
FDA Accepts MyMD Pharmaceuticals Investigational New Drug Application for Phase 2 Study of oral TNF-...
Yahoo News
over a year ago at businesswire.com         
FDA Accepts MyMD Pharmaceuticals Investigational New Drug Application for Phase 2 Study of oral TNF-...
businesswire News
over a year ago at news.google.com         
LQR House Stock , Quotes and News Summary - Benzinga
Google News at Macroaxis
over a year ago at news.google.com         
Mira Pharmaceuticals IPO Fetches 9M, But Filings Spawn More ... - Green Market Report
Google News at Macroaxis
over a year ago at investorplace.com         
Todays Biggest Pre-Market Stock Movers 10 Top Gainers and Losers on Monday
sbwire news
over a year ago at news.google.com         
Sygnature Discovery acquires Canadian CRO NuChem Sciences - FierceBiotech
Google News at Macroaxis
over a year ago at businesswire.com         
MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results
businesswire News
over a year ago at news.google.com         
City of Hopes cancer-killing pill works like a snowstorm shutting ... - FierceBiotech
Google News at Macroaxis
over a year ago at benzinga.com         
Why Is MyMD Pharmaceuticals Stock Gaining Today?
benzinga news
over a year ago at marketwatch.com         
MyMD Shares Surge on Positive Sarcopenia Study Results MYMD
marketwatch News
over a year ago at marketwatch.com         
MyMD Phase 2 Study Hits Key Goals in Age-Related Frailty MYMD
marketwatch News
over a year ago at businesswire.com         
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Gen...
businesswire News
over a year ago at finance.yahoo.com         
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Gen...
Yahoo News
over a year ago at businesswire.com         
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Gen...
businesswire News
over a year ago at businesswire.com         
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Gen...
businesswire News
Far too much social signal, news, headlines, and media speculation about MyMD Pharmaceuticals that are available to investors today. That information is available publicly through MyMD media outlets and privately through word of mouth or via MyMD internal channels. However, regardless of the origin, that massive amount of MyMD data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of MyMD Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of MyMD Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to MyMD Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive MyMD Pharmaceuticals alpha.

MyMD Pharmaceuticals Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
PharmaCyte Biotech Makes 7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
05/21/2024
2
Disposition of 3854626 shares by Pharmacyte Biotech, Inc. of MyMD Pharmaceuticals at 1.816 subject to Rule 16b-3
05/23/2024
3
MyMD Pharmaceuticals Appoints Accomplished Biopharmaceutical Leader and Current Board Member, Mitchell Glass, M.D. as President and Chief Medical Officer
06/17/2024
4
MyMD Pharmaceuticals Announces Corporate Rebranding to New Name TNF Pharmaceuticals, Inc.
07/22/2024
5
TNF Pharmaceuticals Begins Trading Under New Nasdaq Stock Symbol TNFA Effective Before Market Open Today - StockTitan
07/24/2024
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in population.
You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Consideration for investing in MyMD Stock

If you are still planning to invest in MyMD Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the MyMD Pharmaceuticals' history and understand the potential risks before investing.
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Options Analysis
Analyze and evaluate options and option chains as a potential hedge for your portfolios